Among the 55 subjects enrolled, 15 reported adverse events. No serious adverse event was reported. Pain at the injection site was the lone local adverse event. Systemic adverse events reported in Group A were fatigue, headache, diarrhoea, fever, anorexia, nausea and upper respiratory tract infection, whereas there was no systemic event reported in…[Read more]

The tumor microenvironment profoundly influences the behavior of recruited leukocytes and tissue-resident immune cells. These immune cells, which inherently have environmentally driven plasticity necessary for their roles in tissue homeostasis, dynamically interact with tumor cells and the tumor stroma and play critical roles in determining the…[Read more]

Single-cell RNA sequencing (scRNA-seq) is a technology for single-cell transcriptome analysis that can be used to characterize complex dynamics of various retinal cell types. It provides deep scrutiny into the gene expression character of diverse cell types, lending insight into all the biological processes being carried out. The scRNA-seq is an…[Read more]

ve restructuring of the interview process is lacking. With our scoping review, we hope to fill this gap in the literature to better understand barriers to transitioning from face-to-face interviews and directions for future research.

Despite previous literature on the costs associated with face-to-face interviews, there has been hesitancy with…[Read more]

We aimed to clarify the prevalence, indications, analgesic comedications and complications of prescription opioid use in patients presenting to a large emergency department (ED).

Retrospective chart review.

Large, interdisciplinary ED of a public hospital.

All patients aged ≥18 years presenting between 1 January 2017, and 3…[Read more]

We aimed to clarify the prevalence, indications, analgesic comedications and complications of prescription opioid use in patients presenting to a large emergency department (ED).

Retrospective chart review.

Large, interdisciplinary ED of a public hospital.

All patients aged ≥18 years presenting between 1 January 2017, and 3…[Read more]

Mortality among smokers was 29.4% compared to 17.0% among non-smokers. RR was 2.07 (95% CI 1.59, 2.69). Based on analysis of four studies (532 patients), there was no difference in mortality risk between current and former smokers (RR 1.03; 95% CI 0.75, 1.40). Conclusions Smoking, current or past, is associated with higher mortality in COVID-19…[Read more]